AstraZeneca Weighs Continuation of Psoriasis Drug

11.06.2015 - AstraZeneca is mulling whether to independently pursue the developmental psoriasis drug brodalumab after its partner Amgen’s withdrawal from the project in May, Pascal Soriot...